Dyne Therapeutics (DYN) closed at $16.98 on October 28, 2026, up 0.2% from the previous close, on volume of 1,965,087 shares (30-day average 2,878,648).
Data as of October 28, 2026.
28-Oct-2026
Dyne downgraded at Oppenheimer on questions over myotonic dystrophy asset
Seeking Alpha News (Wed, 28-Oct 12:59 PM ET)
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Thu, 22-Oct 4:05 PM ET)
Globe Newswire (Tue, 29-Sep 4:05 PM ET)
Globe Newswire (Tue, 8-Sep 7:51 AM ET)
Globe Newswire (Thu, 3-Sep 7:30 AM ET)
Dyne Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire (Wed, 2-Sep 7:30 AM ET)
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire (Wed, 29-Jul 4:30 PM ET)
Market Chameleon (Wed, 22-Jul 3:06 AM ET)
Market Chameleon (Mon, 20-Jul 4:54 AM ET)
Market Chameleon (Wed, 17-Jun 7:52 AM ET)
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Dyne Therapeutics trades on the NASDAQ stock market under the symbol DYN.
As of October 28, 2026, DYN stock price climbed to $16.98 with 1,965,087 million shares trading.
DYN has a beta of 1.69, meaning it tends to be more sensitive to market movements. DYN has a correlation of 0.09 to the broad based SPY ETF.
DYN has a market cap of $3.17 billion. This is considered a Mid Cap stock.
In the last 3 years, DYN traded as high as $47.45 and as low as $6.36.
The top ETF exchange traded funds that DYN belongs to (by Net Assets): VTI, XBI, IWM, VXF, VB.
DYN has underperformed the market in the last year with a return of -30.1%, while the SPY ETF gained +13.5%. In the last 3 month period, DYN fell short of the market, returning -34.4%, while SPY returned +4.5%. However, in the most recent 2 weeks DYN has outperformed the stock market by returning +12.9%, while SPY returned +0.4%.
DYN support price is $16.25 and resistance is $17.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DYN shares will trade within this expected range on the day.
